tiprankstipranks
Trending News
More News >
Getinge AB (GNGBY)
:GNGBY
Advertisement

Getinge AB (GNGBY) Price & Analysis

Compare
14 Followers

GNGBY Stock Chart & Stats


Getinge AB News

GNGBY FAQ

What was Getinge AB’s price range in the past 12 months?
Getinge AB lowest stock price was $14.99 and its highest was $22.88 in the past 12 months.
    What is Getinge AB’s market cap?
    Getinge AB’s market cap is $6.14B.
      When is Getinge AB’s upcoming earnings report date?
      Getinge AB’s upcoming earnings report date is Oct 21, 2025 which is in 32 days.
        How were Getinge AB’s earnings last quarter?
        Getinge AB released its earnings results on Jul 18, 2025. The company reported $0.199 earnings per share for the quarter, beating the consensus estimate of N/A by $0.199.
          Is Getinge AB overvalued?
          According to Wall Street analysts Getinge AB’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Getinge AB pay dividends?
            Getinge AB pays a Annually dividend of $0.478 which represents an annual dividend yield of 2.12%. See more information on Getinge AB dividends here
              What is Getinge AB’s EPS estimate?
              Getinge AB’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Getinge AB have?
              Getinge AB has 254,152,370 shares outstanding.
                What happened to Getinge AB’s price movement after its last earnings report?
                Getinge AB reported an EPS of $0.199 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.113%.
                  Which hedge fund is a major shareholder of Getinge AB?
                  Currently, no hedge funds are holding shares in GNGBY

                  Company Description

                  Getinge AB

                  Getinge AB is a global medical technology company based in Sweden, specializing in products and solutions for healthcare and life sciences. The company operates in three primary sectors: Surgical Workflows, Critical Care, and Life Science. Getinge's core offerings include advanced surgical equipment, anesthesia machines, intensive care unit solutions, sterilization products, and biopharmaceutical manufacturing systems. With a strong focus on innovation and efficiency, Getinge aims to improve patient outcomes and streamline healthcare operations worldwide.

                  Getinge AB (GNGBY) Earnings & Revenues

                  GNGBY Company Deck

                  GNGBY Earnings Call

                  Q2 2025
                  0:00 / 0:00
                  Earnings Call Sentiment|Positive
                  The earnings call presented a generally positive outlook with strong organic growth and improved margins, despite significant headwinds from tariffs and FX. Regulatory and quality improvements, along with successful strategic acquisitions, bolster the positive sentiment. However, challenges in the Life Science segment and market share losses in certain product categories are notable concerns.View all GNGBY earnings summaries
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Insulet
                  Koninklijke Philips
                  Smith & Nephew Snats
                  Steris
                  Zimmer Biomet Holdings

                  Ownership Overview

                  0.03%99.97%
                  Insiders
                  Mutual Funds
                  0.03% Other Institutional Investors
                  99.97% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis